ARCHIVE

• Data on Similar Drugs Required for Risk Benefit Analysis: RAD-AR Council Japan
  April 7, 2003

• Nihon Schering Publishes Its 50-year History
  April 7, 2003

• Korosho Issues Checklist to Promote GE Drug Use in Nat'l Hospital
  April 7, 2003

• Atypical Antipsychotic Agents Useful in Maintenance Therapy
  April 7, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  April 7, 2003

• Proposed Basic Policy Calls For Operation of Health Insurance Programs by Prefecture
  April 7, 2003

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  April 7, 2003

• WORLD NEWS IN BRIEF
  April 7, 2003

• Strict Safety Measures Required for GE Pravastatin, Simvastatin
  April 7, 2003

• BULLETIN
  April 7, 2003

• METI Stresses Need for Protection of NDA Data
  April 7, 2003

• Yamanouchi Global Strategy Focusing on Urology: President Takenaka
  April 7, 2003

• New ADRs of Allopurinol, Hydroxycarbamide Reported
  April 7, 2003

• Nidek, Otsuka to Comarket Toyama's New Quinolone Eye Drop
  April 7, 2003

• 10 Advanced Medical Technologies Approved
  April 7, 2003

• Ushioda Sangokudo Acquires Kuraya Sanseido's North Kanto Business
  April 7, 2003

• Test Conditions Announced for 24th Quality Reevaluation
  April 7, 2003

• BUSINESS NEWS IN BRIEF
  April 7, 2003

• REGULATORY NEWS IN BRIEF
  April 7, 2003

• Social Sec. Premiums to Account for 13.5% of Household Costs in 2025
  April 7, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 606
• 607
• 608
• 609
• 610
• 611
• 612
• 613
• 614
• …
• Next ›
• 最終 »